Clinical Trial Update: Mesoglycan, Vascular Reactivity and Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update showing completion of a mesoglycan study assessing vascular reactivity in metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Mesoglycan (mesoglycan)

Snippet

Sponsor: Federico II University | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED